Kidney Involvement in COVID-19 Disease (COVKID)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-15

Study Completion Date

2020-04-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Novel coronavirus disease (COVID-19) is a newly discovered contagious disease caused by SARS-CoV-2 virus, primarily manifesting as an acute respiratory illness with pneumonia, but can affect multiple organs such as kidney, heart, digestive tract, blood and nervous system. In previous reports of SARS and MERS-CoV infections, acute kidney injury was described in 5 to 15% of patients and was associated with a high mortality rate (60-90%). Recent reports showed renal abnormalities in COVID-9 infected patients. A recent Chinese study also reported that acute kidney injury was an independent risk factor for mortality. However, the exact mechanism of kidney involvement remains unclear: sepsis-related cytokine storm or direct cellular injury from the virus. Also, kidney involvement has not yet been well characterized: heavy albuminuria, hematuria or interstitial nephropathy alone.

A recent study identified viral RNA in kidney tissue and another study succeeded isolating SARS-CoV-2 from the urine sample of an infected patient. These data suggest that the kidney might be a target of this novel coronarivus.

The sponsor suggests characterizing kidney involvement in SARS-CoV-2 infection.

Study objectives are:

* To give an accurate characterization of kidney involvement in COVID-19
* To investigate the physiopathologic mechanism of kidney involvement in SARS-CoV-2 infection
* To identify risk factors for kidney involvement in in SARS-CoV-2 infection
* To evaluate the impact of kidney involvement in in SARS-CoV-2 infection
* To assess the long-term health effect of kidney injury on survivors of in SARS-CoV-2 infection

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

KIDney Injury in Times of COVID-19 (KIDCOV)

NCT04705766

SARS-CoV Infection Covid19 Corona Virus Infection +2 more

RECRUITING

Acute Kidney Dysfunction in COVID-19 and Non-COVID-19 Related ARDS

NCT05699889

COVID-19 Acute Respiratory Distress Syndrome Acute Kidney Injury Due to COVID-19

COMPLETED

Patients With Acute Renal Failure During Severe COVID-19

NCT05077163

Renal Failure Chronic

UNKNOWN

Kidney Disease After COVID-19

NCT05328986

COVID-19 Acute Kidney Injury Chronic Kidney Injury

COMPLETED

Kidney in Coronavirus Disease 2019 Registry

NCT04797091

Corona Virus Infection SARS-CoV 2

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU patients

COVID-19 patients admitted in Intensive Care Units

No interventions assigned to this group

Non ICU patients

COVID-19 patients admitted in conventional units

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed COVID-19 disease
* Age \> 18 years-old

Exclusion Criteria

* Age \< 18 years-old
* Pregnancy
* Patient with tutor- or curatorship or in prison
* Patients who had undergone renal replacement therapy (RRT) before admission

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No